Literature DB >> 17084806

The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling.

Catalina Ribas1, Petronila Penela, Cristina Murga, Alicia Salcedo, Carlota García-Hoz, María Jurado-Pueyo, Ivette Aymerich, Federico Mayor.   

Abstract

G protein-coupled receptor kinases (GRKs) and arrestins are key participants in the canonical pathways leading to phosphorylation-dependent GPCR desensitization, endocytosis, intracellular trafficking and resensitization as well as in the modulation of important intracellular signaling cascades by GPCR. Novel studies have revealed a phosphorylation-independent desensitization mechanism operating through their RGS-homology (RH) domain and the recent determination of the crystal structures of GRK2 and GRK6 has uncovered interesting details on the structure-function relationships of these kinases. Emerging evidence indicates that the activity of GRKs is tightly modulated by mechanisms including phosphorylation by different kinases and interaction with several cellular proteins such as calmodulin, caveolin or RKIP. In addition, GRKs are involved in multiple interactions with non-receptor proteins (PI3K, Akt, GIT or MEK) that point to novel GRK cellular roles. In this article, our purpose is to describe the ever increasing map of functional interactions for GRK proteins as a basis to better understand its contribution to cellular processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084806     DOI: 10.1016/j.bbamem.2006.09.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  162 in total

1.  Role of myeloid-specific G-protein coupled receptor kinase-2 in sepsis.

Authors:  Sitaram Parvataneni; Babu Gonipeta; Nandakumar Packiriswamy; Taehyung Lee; Haritha Durairaj; Narayanan Parameswaran
Journal:  Int J Clin Exp Med       Date:  2011-11-09

2.  Overlapping and distinct roles of GRK5 in TLR2-, and TLR3-induced inflammatory response in vivo.

Authors:  Nandakumar Packiriswamy; Sitaram Parvataneni; Narayanan Parameswaran
Journal:  Cell Immunol       Date:  2011-10-28       Impact factor: 4.868

Review 3.  Opioid receptor trafficking and signaling: what happens after opioid receptor activation?

Authors:  Jia-Ming Bian; Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2011-09-25       Impact factor: 5.046

Review 4.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 5.  Tumor necrosis factor-α signaling in macrophages.

Authors:  Narayanan Parameswaran; Sonika Patial
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

Review 6.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

7.  Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.

Authors:  Christian Doll; Florian Pöll; Kenneth Peuker; Anastasia Loktev; Laura Glück; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 8.  Development of small molecules targeting the Wnt pathway for the treatment of colon cancer: a high-throughput screening approach.

Authors:  Wei Chen; Minyong Chen; Larry S Barak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-27       Impact factor: 4.052

9.  Overexpression of GRK6 associates with the progression and prognosis of colorectal carcinoma.

Authors:  Ran Tao; Qiang Li; Xiaofei Gao; Lilin Ma
Journal:  Oncol Lett       Date:  2018-02-12       Impact factor: 2.967

10.  GRK3 is essential for metastatic cells and promotes prostate tumor progression.

Authors:  Wenliang Li; Nanping Ai; Suming Wang; Nandita Bhattacharya; Vladimir Vrbanac; Michael Collins; Sabina Signoretti; Yanhui Hu; Frederick M Boyce; Karsten Gravdal; Ole J Halvorsen; Hawa Nalwoga; Lars A Akslen; Ed Harlow; Randolph S Watnick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.